SCHIZOPHRENIA BULLETIN

Scope & Guideline

Leading the discourse in psychiatry and mental health.

Introduction

Welcome to your portal for understanding SCHIZOPHRENIA BULLETIN, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0586-7614
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1973 to 2024
AbbreviationSCHIZOPHRENIA BULL / Schizophr. Bull.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The 'Schizophrenia Bulletin' focuses on advancing the understanding of schizophrenia and related disorders through a multidisciplinary approach. The journal aims to disseminate high-quality research that spans various aspects of schizophrenia, including neurobiological, psychological, and social dimensions.
  1. Neurobiological Mechanisms:
    Research exploring the underlying neurobiological mechanisms of schizophrenia, including genetics, neuroimaging, and molecular biology, to better understand the pathophysiology of the disorder.
  2. Psychological and Cognitive Aspects:
    Studies examining cognitive deficits, emotional regulation, and psychosocial factors that contribute to the experience of schizophrenia, emphasizing the interplay between mental processes and symptoms.
  3. Treatment and Intervention Strategies:
    Investigations into pharmacological and non-pharmacological interventions, including cognitive remediation, psychosocial therapies, and innovative treatment approaches such as digital health interventions.
  4. Epidemiological and Public Health Perspectives:
    Research addressing epidemiology, risk factors, and health disparities related to schizophrenia, focusing on societal impacts and the effectiveness of public health strategies.
  5. Transdiagnostic Approaches:
    Explorations of concepts that span various psychiatric disorders, including the study of psychosis risk and shared mechanisms with other mental health conditions.
The 'Schizophrenia Bulletin' has shown a dynamic shift in focus towards emerging themes that resonate with current clinical and societal needs in the field of schizophrenia research.
  1. Digital Health Interventions:
    A growing number of studies explore the efficacy of digital health technologies, such as teletherapy and mobile health applications, highlighting their potential to improve access to care and patient outcomes.
  2. Transdiagnostic Research:
    An increase in research that examines psychosis across various diagnostic categories, emphasizing shared mechanisms and risk factors, reflecting a move towards understanding mental health in a more integrated manner.
  3. Cognitive Remediation and Functionality:
    There is a notable rise in studies investigating cognitive remediation strategies aimed at improving functional outcomes in individuals with schizophrenia, indicating a shift towards enhancing quality of life.
  4. Social and Environmental Factors:
    Emerging research emphasizes the role of social determinants, such as socioeconomic status and childhood adversity, in the onset and progression of schizophrenia, underscoring the need for a holistic understanding of the disorder.
  5. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence to predict treatment responses, identify biomarkers, and enhance diagnostic accuracy is on the rise, indicating a trend towards incorporating advanced technology in psychiatric research.

Declining or Waning

While the journal continues to cover a broad range of topics, certain areas of research appear to be declining in prominence based on recent publications.
  1. Historical Perspectives on Antipsychotic Medications:
    Although historical analyses of antipsychotic medications have been foundational, recent publications indicate a shift towards contemporary research focusing on innovative interventions and current treatment paradigms.
  2. Single-Disease Focus:
    There seems to be a waning emphasis on studies that exclusively examine schizophrenia without considering comorbid conditions or broader psychiatric contexts, reflecting a trend towards more integrated approaches.
  3. Basic Science Studies:
    The volume of purely basic science studies, such as animal models without translational implications, appears to be decreasing, as the journal increasingly prioritizes research with direct clinical relevance.

Similar Journals

Psychogeriatrics

Pioneering research in geriatric mental health.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

PSYCHOLOGICAL MEDICINE

Fostering innovation in psychiatric science.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

BRITISH JOURNAL OF PSYCHIATRY

Pioneering Discoveries in Psychiatric Science
Publisher: CAMBRIDGE UNIV PRESSISSN: 0007-1250Frequency: 12 issues/year

British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

Frontiers in Psychiatry

Pioneering Research for a Healthier Mind
Publisher: FRONTIERS MEDIA SAISSN: 1664-0640Frequency: 1 issue/year

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Bridging Disciplines for Comprehensive Mental Health Solutions
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

Schizophrenia Research

Unraveling the mysteries of schizophrenia through cutting-edge studies.
Publisher: ELSEVIERISSN: 0920-9964Frequency: 12 issues/year

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

CURRENT OPINION IN PSYCHIATRY

Shaping Tomorrow's Psychiatry Today
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0951-7367Frequency: 6 issues/year

Current Opinion in Psychiatry is a premier journal published by Lippincott Williams & Wilkins, dedicated to the dynamic and evolving field of psychiatry and mental health. With a commendable impact factor and ranking 30th out of 567 in the Scopus database, this journal occupies a Q1 quartile position, reflecting its significance and influence within the academic community. Since its inception in 1988, Current Opinion in Psychiatry has aimed to provide critical reviews, leading research, and expert opinions that shape clinical practice and decision-making in psychiatry. While the journal is not open access, it continues to serve as an essential resource for researchers, clinicians, and students seeking insights into contemporary psychiatric challenges and advancements. With its ongoing commitment to high-quality content, the journal remains a vital platform for knowledge dissemination and dialog in the field.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Fostering Understanding of Neurological and Psychiatric Disorders
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Transforming geriatric psychiatry through impactful insights.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

JAMA Psychiatry

Exploring the Frontiers of Psychiatry and Clinical Practice
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.